Navigation Links
Labopharm announces details for first quarter results conference call and annual meeting
Date:4/23/2009

LAVAL, QC, April 23 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the dates and times of its first quarter fiscal 2009 results conference call and Annual Meeting of Shareholders.

First Quarter Results Conference Call

On Thursday, May 7 at 8:30 a.m. (ET) Labopharm will host a conference call to discuss its first quarter 2009 financial results. Labopharm will report its first quarter 2009 financial results via news release at approximately 7:00 a.m. the same day.

To access the conference call by telephone, dial 416-644-3420 or 1-800-732-0232. Please connect approximately 15 minutes prior to the beginning of the call to ensure participation. The conference call will be archived for replay until Thursday, May 14, 2009 at midnight. To access the archived conference call, dial 416-640-1917 or 1-877-289-8525 and enter the reservation number 21303738 followed by the number sign.

A live audio webcast of the conference call will be available at www.labopharm.com. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived at the above web site for 30 days.

Annual Meeting of Shareholders

Labopharm will hold its Annual Meeting of Shareholders on Thursday, May 7 at 11:00 am ET at the Montreal Museum of Fine Arts, Maxwell-Cummings Auditorium, 1379 Sherbrooke Street West, Montreal, Quebec.

A live webcast of the meeting will be available at www.labopharm.com. Please connect at least 15 minutes prior to the meeting to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archi
'/>"/>

SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... To further educate the public, The Rothenberg ... safety information regarding leaving children in hot vehicles: , ... consequences. Because a child’s body can heat up three ... children alone in a hot vehicle puts them at ... Statistics of Children Left Alone in a Car , ...
(Date:7/31/2014)... Texas (PRWEB) July 31, 2014 ... Austin-based physicians Tracey Haas and Tim Gueramy, announced the ... Docbook Enterprise. , According to Dr. Tim Gueramy, CEO ... their solution because physician leaders from each one had ... saw a huge benefit for their respective organizations to ...
(Date:7/31/2014)... Johns Hopkins have developed blood and saliva tests that ... a substantial number of patients. The tests screen for ... cancer cells lingering in the mouth or other parts ... published in the July 31 issue of JAMA ... is a window of opportunity in the year after ...
(Date:7/31/2014)... Rich Dad® Education , a leader in financial ... for Humanity. The yard sale was a success. In just ... proceeds donated to Habitat for Humanity of Lee and Hendry ... were donated to the Habitat for Humanity ReStore thrift store ... , Of the over $650, roughly $30 was raised ...
(Date:7/31/2014)... -- With the World Health Organization reporting that the ... risen to 729, the U.S. Centers for Disease ... for,the region. The "Level 3 travel advisory" urges ... Guinea, Liberia and Sierra Leone -- be avoided. ... West Africa," CDC Director Dr. Tom Frieden told reporters ...
Breaking Medicine News(10 mins):Health News:The Rothenberg Law Firm LLP Teams Up with Local Philadelphia TV Stations to Promote Awareness of the Dangers of Leaving Children Unattended in a Hot Vehicle 2Health News:The Rothenberg Law Firm LLP Teams Up with Local Philadelphia TV Stations to Promote Awareness of the Dangers of Leaving Children Unattended in a Hot Vehicle 3Health News:Physician Demand for Integrated Communication Platform Drives DocbookMD Growth 2Health News:Blood and saliva tests help predict return of HPV-linked oral cancers 2Health News:Rich Dad Education Charity Yard Sale to Benefit Habitat for Humanity of Lee and Hendry Counties a Success 2Health News:CDC Issues Travel Warning as West Africa Ebola Outbreak Worsens 2
... July 14, 2009 Infectious disease specialists at UT Southwestern ... severe Staphylococcus aureus infections, providing crucial insight ... to this pathogen and opening new doors for improved therapeutic ... on understanding precisely what the bacterium S aureus does ...
... , DENVER, July 13 DaVita Inc. (NYSE: ... with chronic kidney disease (CKD), today announced Mahesh Krishnan, MD, MPH has ... July 13, 2009. , , (Logo: ... is recognized as a leader in clinical trials for drugs and devices. ...
... , DENVER, July 13 ... Luncheon will be held in Denver July 23 at the ... luncheon, sponsored by MillerCoors, will honor and welcome Her Excellency, ... annual fundraising event raises awareness of global healthcare needs and ...
... , ... The Extraordinary Leader, performance thought leaders John Zenger and Joseph Folkman revealed the 16 ... first book,s publication, they have discovered, through an extensive study conducted over four years, that ... ...
... A new study of the cognitive processes involved with ... temptation than active resistance to temptation. Using ... given the chance to gain money dishonestly by lying ... activity when telling the truth, implying that extra cognitive ...
... , , , Gail ... Sector in Current Economic Climate , , ... Cross will be the featured speaker at a National Press Club Luncheon on Tuesday, ... through Turbulent Economic Times." , , (Logo: ...
Cached Medicine News:Health News:Researchers map how staph infections alter immune system 2Health News:Researchers map how staph infections alter immune system 3Health News:DaVita Clinical Research Appoints Mahesh Krishnan as Vice President 2Health News:DaVita Clinical Research Appoints Mahesh Krishnan as Vice President 3Health News:Project C.U.R.E. and MillerCoors to Welcome the First Lady of Ghana to Colorado for First Ladies' Luncheon in Denver 2Health News:Project C.U.R.E. and MillerCoors to Welcome the First Lady of Ghana to Colorado for First Ladies' Luncheon in Denver 3Health News:Project C.U.R.E. and MillerCoors to Welcome the First Lady of Ghana to Colorado for First Ladies' Luncheon in Denver 4Health News:Zenger Folkman Releases Latest Book: The Inspiring Leader: Unlocking the Secrets of How Extraordinary Leaders Motivate 2Health News:Zenger Folkman Releases Latest Book: The Inspiring Leader: Unlocking the Secrets of How Extraordinary Leaders Motivate 3Health News:Neuroimaging suggests that truthfulness requires no act of will for honest people 2Health News:Neuroimaging suggests that truthfulness requires no act of will for honest people 3Health News:American Red Cross President to Address National Press Club Luncheon 2
(Date:7/31/2014)... Calif., July 31, 2014 STAAR Surgical Company ... and marketer of implantable lenses and delivery systems for ... ended July 4, 2014 of $20.0 million, a 10% ... of 2013. On a constant currency basis, revenues grew ... the second quarter of 2013.  The effect of foreign ...
(Date:7/31/2014)... 2014 Pharmacyclics, Inc. (the "Company") (Nasdaq: ... the quarter ended June 30, 2014. Financial Results ... Revenue Total revenue for the quarter ended June 30, ... quarter ended June 30, 2013 primarily due to IMBRUVICA ® ... Total revenue for the six months ended June 30, ...
(Date:7/31/2014)... -- UBM Medica US announces that Cancer Network ... exclusive slide shows dealing with communication in the oncology ... Cancer Network, the online home ... and podcasts about the latest clinical findings. Among the ... , End-of-life care is challenging for even the most ...
Breaking Medicine Technology:STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26STAAR Surgical Reports 10% Second Quarter Revenue Growth 27STAAR Surgical Reports 10% Second Quarter Revenue Growth 28STAAR Surgical Reports 10% Second Quarter Revenue Growth 29STAAR Surgical Reports 10% Second Quarter Revenue Growth 30STAAR Surgical Reports 10% Second Quarter Revenue Growth 31Pharmacyclics Reports Second Quarter 2014 Results 2Pharmacyclics Reports Second Quarter 2014 Results 3Pharmacyclics Reports Second Quarter 2014 Results 4Pharmacyclics Reports Second Quarter 2014 Results 5Pharmacyclics Reports Second Quarter 2014 Results 6
... Imaging announced today that it has received FDA 510(k) ... Analyzer® System to assess coronary branch vessels in addition ... artery disease (CAD). The clearance is the third for ... tool that automatically detects significant (50 percent and over) ...
... Medical, Inc., a private sports medicine device company specializing ... immediately, David B. Springer will succeed James Hart as ... Executive Chairman due to health reasons. Hart, ... CEO since the company,s inception in 2005, will continue ...
Cached Medicine Technology:Rcadia COR Analyzer System Receives Expanded FDA Clearance to Rule Out Coronary Artery Disease in Coronary Branch Vessels 2Cayenne Medical, Inc. Appoints David B. Springer President & CEO 2Cayenne Medical, Inc. Appoints David B. Springer President & CEO 3
... the state of the art product for ... articular surfaces does not restrict natural movement, ... a wide area of contact between the ... of cement create a homogeneous cement mantle ...
... The TC-PLUS Solution tricompartmental total knee ... with knee arthroplasty. State-of-the-art design and manufacturing ... achieve optimum biomechanical function as well as ... polyethylene tibial insert to keep wear to ...
The RT-PLUS Solution is an axially supported rotation knee prosthesis for cemented implantation. The modern design allows extremely sparing resections. The components exhibit an anatomical geometry t...
... System is a long term, quality solution ... in both posterior stabilized and anatomically correct ... provides the flexibility needed to address patients' ... of identification keeps the user in mind ...
Medicine Products: